Neogen Corporation Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Neogen Corporation (NEOG) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $5.93 per share for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-07-30
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-08-31 was $0.00.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-08-31 was $0.00.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-08-31 was $0.00.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2018-08-31 was $0.00, a 100.00% decline year-over-year.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was $5.93, a 61.67% decline from fiscal 2025.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $15.47, a 0.26% increase from fiscal 2024.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $15.43, a 5.11% increase from fiscal 2023.
- Neogen Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $14.68, a 59.69% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-05-31 | $5.93 10-K · filed 2026-07-30 | ||||
| 2025-05-31 | $15.47 10-K · filed 2026-07-30 | ||||
| 2024-05-31 | $15.43 10-K · filed 2026-07-30 | ||||
| 2023-05-31 | $14.68 10-K · filed 2025-07-30 | ||||
| 2022-11-30 | $14.63 10-Q · filed 2023-01-09 | ||||
| 2022-08-31 | $0.00 10-Q · filed 2022-09-30 | ||||
| 2022-05-31 | $36.42 10-K · filed 2024-07-30 | ||||
| 2022-02-28 | $40.93 10-Q · filed 2022-04-01 | ||||
| 2021-11-30 | $40.93 10-Q · filed 2021-12-30 | ||||
| 2021-08-31 | $0.00 10-Q · filed 2021-09-30 | ||||
| 2021-05-31 | $34.23 10-K · filed 2023-08-15 | ||||
| 2021-02-28 | $68470.00 10-Q · filed 2021-03-31 | ||||
| 2020-11-30 | $68.47 10-Q · filed 2020-12-29 | ||||
| 2020-08-31 | $0.00 10-Q · filed 2020-09-30 | ||||
| 2020-05-31 | $31.96 10-K · filed 2022-07-27 | $63.91 10-K · filed 2020-07-30 | |||
| 2020-02-29 | $63.91 10-Q · filed 2020-04-03 | ||||
| 2019-11-30 | $63.91 10-Q · filed 2019-12-27 | ||||
| 2019-05-31 | $31.46 10-K · filed 2021-07-30 | $62.92 10-K · filed 2019-07-30 | |||
| 2019-02-28 | $62.92 10-Q · filed 2019-03-29 | ||||
| 2018-11-30 | $62.93 10-Q · filed 2018-12-28 | ||||
| 2018-08-31 | $0.00 10-Q · filed 2018-10-05 | ||||
| 2018-05-31 | $59.37 10-K · filed 2020-07-30 | ||||
| 2018-02-28 | $59.26 10-Q · filed 2018-03-29 | ||||
| 2017-11-30 | $59.26 10-Q · filed 2018-01-05 | ||||
| 2017-08-31 | $63.95 10-Q · filed 2017-09-29 | ||||
| 2017-05-31 | $40.68 10-K · filed 2019-07-30 | $54.24 10-K · filed 2017-07-28 | |||
| 2017-02-28 | $54.19 10-Q · filed 2017-03-31 | ||||
| 2016-11-30 | $53.99 10-Q · filed 2016-12-29 | ||||
| 2016-08-31 | $0.00 10-Q · filed 2016-09-30 | ||||
| 2016-05-31 | $35.23 10-K · filed 2018-07-27 | $46.98 10-K · filed 2016-07-29 | |||
| 2016-02-29 | $46.98 10-Q · filed 2016-03-31 | ||||
| 2015-11-30 | $46.98 10-Q · filed 2016-01-08 | ||||
| 2015-08-31 | $0.00 10-Q · filed 2015-09-30 | ||||
| 2015-05-31 | $39.79 10-K · filed 2017-07-28 | ||||
| 2015-02-28 | $39.79 10-Q · filed 2015-04-01 | ||||
| 2014-11-30 | $39.69 10-Q · filed 2014-12-30 | ||||
| 2014-08-31 | $0.00 10-Q · filed 2014-09-30 | ||||
| 2014-05-31 | $36.44 10-K · filed 2016-07-29 | ||||
| 2014-02-28 | $36.44 10-Q · filed 2014-04-04 | ||||
| 2013-11-30 | $36.44 10-Q · filed 2014-01-09 | ||||
| 2013-08-31 | $14.65 10-Q · filed 2013-09-30 | ||||
| 2013-05-31 | $28.67 10-K · filed 2015-07-30 | $43.00 10-K · filed 2013-07-30 | |||
| 2013-02-28 | $43.00 10-Q · filed 2013-03-28 | ||||
| 2012-11-30 | $43.00 10-Q · filed 2012-12-28 | ||||
| 2012-08-31 | $0.00 10-Q · filed 2012-09-28 | ||||
| 2012-05-31 | $23.06 10-K · filed 2014-07-30 | $34.59 10-K · filed 2012-07-30 | |||
| 2011-05-31 | $28.50 10-K · filed 2013-07-30 | ||||
| 2010-05-31 | $19.60 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |